Product Browser

Last updated: 2017/3/19

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

NDUFA8 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00004702-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-NDUFA8 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 19.03
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-NDUFA8 antibody (H00004702-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00004702-T01
    NDUFA8 transfected lysate.
    Western Blot
    QC Testing of H00004702-T01
    Lane 1: NDUFA8 transfected lysate ( 19.03 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 4702
  • Gene Name:
  • NDUFA8
  • Gene Alias:
  • CI-19KD,CI-PGIV,MGC793,PGIV
  • Gene Description:
  • NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa
  • Gene Summary:
  • The protein encoded by this gene belongs to the complex I 19 kDA subunit family. Mammalian complex I is composed of 45 different subunits. This protein has NADH dehydrogenase activity and oxidoreductase activity. It plays an important role in transfering electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. [provided by RefSeq
  • Other Designations:
  • NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (19kD, PGIV),NADH-ubiquinone oxidoreductase 19 kDa subunit,NADH:ubiquinone oxidoreductase PGIV subunit,OTTHUMP00000022034
  • RSS
  • YouTube
  • Linkedin
  • Facebook